556-570 of 813
Brian P. McDonough, MD, FAAFP
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 3
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 3
Matt Birnholz, MD
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 2
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 2
Matt Birnholz, MD
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 1
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 1
Matt Birnholz, MD
Spotlight on Meningiomas: Risks and Clinical Manifestations
NeuroFrontiersSpotlight on Meningiomas: Risks and Clinical Manifestations
Anthony Alessi, MD
Lynn Taylor, MD
Anthony Alessi, MD
Jeffrey Kutcher, MD, FAAN
- advertisement
Treating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
NeuroFrontiersTreating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
Anthony Alessi, MD
Vera Bril, MD
How Smart Phones Are Improving Neurologic Care
NeuroFrontiersHow Smart Phones Are Improving Neurologic Care
Anthony Alessi, MD
Neil Busis, MD
The Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
NeuroFrontiersThe Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
Anthony Alessi, MD
Lisa Shulman
Neurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
Medical Breakthroughs from Penn MedicineNeurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
Lee Freedman, MD
Neil Malhotra, MD
Endoscopic Brain Surgery, In 3-D
Medical Breakthroughs from Penn MedicineEndoscopic Brain Surgery, In 3-D
Lee Freedman, MD
John Y.K. Lee, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Matt Birnholz, MD
- advertisement
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Matt Birnholz, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Matt Birnholz, MD
Focusing on Comfort in Caring for Patients with Dementia and Alzheimer's
Advances in Long Term Care MedicineFocusing on Comfort in Caring for Patients with Dementia and Alzheimer's
Eric Tangalos, MD
Tena Alonzo, MA
